- Home
- CTMX vs YSXT Comparison
CTMX vs YSXT Comparison
Compare CTMX & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTMX | YSXT |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 35.9M |
| IPO Year | 2015 | 2024 |
Fundamental Metrics
Financial Performance| Metric | CTMX | YSXT |
|---|---|---|
| Price | $3.92 | $1.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 1.1M |
| Earning Date | 11-06-2025 | 07-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.22 | N/A |
| EPS | ★ 0.24 | 0.18 |
| Revenue | ★ $113,631,000.00 | $71,452,736.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.20 | ★ $7.30 |
| Revenue Growth | N/A | ★ 22.04 |
| 52 Week Low | $0.40 | $1.13 |
| 52 Week High | $4.62 | $9.96 |
Technical Indicators
Market Signals| Indicator | CTMX | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 48.63 | 29.22 |
| Support Level | $3.78 | $1.25 |
| Resistance Level | $4.37 | $1.80 |
| Average True Range (ATR) | 0.26 | 0.34 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 33.57 | 13.64 |
Price Performance
Historical ComparisonAbout CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.